Medical Program: An Oncologist’s Priorities for Managing Adverse Events in NSCLC Care

An Oncologist’s Priorities for Managing Adverse Events in NSCLC Care

An Oncologist’s Priorities for Managing Adverse Events in NSCLC Care
RestartResume

Do you know the most common—and oftentimes severe—adverse events non-small cell lung cancer patients receiving immunotherapies can experience?

  • Overview

    The therapies that have been approved for non-small cell lung cancer stimulate the immune system to attack cancer cells… But what happens when they do too good a job of that and stimulate the immune system to inflame other parts of the body as well? Dr. Michael Shafique from the Moffitt Cancer Center breaks down the most common adverse events to look for in patients with non-small cell lung cancer.

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free